XML 65 R45.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Domestic and Foreign Components of (Loss) Income Before Provision for Income Taxes on Continuing Operations
The domestic and foreign components of (loss) income before provision for income taxes on continuing operations were as follows:
Year Ended December 31,
202420232022
Domestic$(33,156)$(59,254)$(108,766)
Foreign(138)5,144 (6,063)
Total loss before income taxes$(33,294)$(54,110)$(114,829)
Schedule of Provision (Benefit) for Income Taxes On Continuing Operations
The provision / (benefit) for income taxes on continuing operations consisted of the following:
Year Ended December 31,
202420232022
Current provision / (benefit)
Federal$— $— $
State49 92 77 
Foreign956 (1,689)2,756 
Total current provision / (benefit)$1,005 $(1,597)$2,835 
Deferred (benefit) / provision
Federal$$$726 
State11 (4)230 
Foreign(355)3,200 (1,061)
Total deferred (benefit) / provision$(343)$3,199 $(105)
Total provision / (benefit)
Federal$$$728 
State60 88 307 
Foreign601 1,511 1,695 
Total provision / (benefit)$662 $1,602 $2,730 
Schedule of Reconciliation of the U.S. Statutory Income Tax Rate On Continuing Operations to the Company's Effective Tax Rate
A reconciliation of the U.S. federal statutory income tax rate on continuing operations of 21% for the years ended December 31, 2024, 2023, and 2022 to the Company’s effective tax rate is as follows:
Year Ended December 31,
202420232022
Income tax (benefit) provision at the U.S. federal statutory rate$(6,974)$(11,363)$(24,114)
State income taxes(793)(1,331)(1,045)
Permanent differences157 (50)380 
Change in valuation allowance8,230 10,580 12,397 
Effect of foreign operations171 1,837 (147)
Stock-based compensation733 1,728 4,205 
Section 162(m)261 221 493 
Derivative and warrant liabilities288 (36)(1,940)
U.S. GILTI inclusion(511)511 139 
Goodwill impairment— — 10,615 
Effect of change in tax rates667 58 
Research and development tax credits(2,135)— — 
Foreign currency translation and transactions356 (237)560 
Other212 (264)1,129 
Total provision (benefit) for income taxes$662 $1,602 $2,730 
Schedule of Significant Components of Deferred Tax Assets and Deferred Tax Liabilities
Significant components of deferred tax assets and liabilities as of December 31, 2024 and 2023 were as follows:
Year Ended December 31,
20242023
Deferred tax assets
Net operating loss carryforwards$115,007 $104,168 
Accruals2,248 2,119 
Stock-based compensation747 1,083 
Bad debt182 255 
Interest expense5,220 3,630 
Lease liabilities9,069 14,442 
Section 174 capitalized R&D costs9,521 13,057 
Capitalized production expenses213 330 
Other1,803 1,733 
Total deferred tax asset$144,010 $140,817 
Valuation allowance(125,613)(117,526)
Net deferred tax asset$18,397 $23,291 
Deferred tax liabilities
Deferred state income tax(3,208)(3,174)
Operating lease, right-of-use asset(6,960)(11,334)
Depreciation and amortization— (710)
Intangible assets(7,938)(8,105)
Total deferred tax liability$(18,106)$(23,323)
Net deferred tax asset (liability)$291 $(32)
Schedule of Income Tax Examinations The earliest years’ tax returns filed by the Company that are still subject to examination by the tax authorities in the major jurisdictions are as follows:
Years
United States2020
United Kingdom2023
Japan2019
Canada2020